Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle Ferrant

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 26, 2020
Overall survival benefit of symptom monitoring in real-world patients with chronic lymphocytic leukaemia treated with ibrutinib: a FiLO group studyLoic Ysebaert, Anne Quinquenel, Fontané Bijou, et al.
Bulletin Du Cancer|January 29, 2019
Gilles Salles, Pierre Sesques, Emmanuelle Ferrant, et al.
Bulletin Du Cancer|November 6, 2007
[Angiogenesis targeting in breast cancer]Pierre Fumoleau, Bruno Coudert, Françoise Mayer, et al.
International Journal of Clinical Pharmacy|September 27, 2015
De-escalation chemotherapy and hematological profiles in patients with advanced Hodgkin's lymphomaAntoine Seignez, Olivier Casasnovas, Emmanuelle Ferrant, et al.
Cancer Cell|January 30, 2022
Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor T cell immunotherapy recipientsPierre Sesques, Emmanuel Bachy, Emmanuelle Ferrant, et al.
Gastroenterologie Clinique Et Biologique|January 27, 2005
[Sustained clinical response of large hepatocellular carcinoma after chemoembolization with pirarubicin, amiodarone and Lipiodol]Jean-Pierre Cercueil, Emmanuelle Ferrant, Nicolas Isambert, et al.
Clinical Case Reports|December 22, 2021
Crystal-storing histiocytosis and Bing-Neel-like syndrome revealing a small B-cell lymphoma with plasmacytic differentiation, presumed to be a marginal zone lymphomaHippolyte Lequain, Mathieu Gerfaud-Valentin, Juliette Fontaine, et al.
Leukemia|January 31, 2020
Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemiaSarah Huet, Anne Bouvard, Emmanuelle Ferrant, et al.
Breast (Edinburgh, Scotland)|August 19, 2007
Results of a phase I trial of intravenous vinorelbine plus oral capecitabine as first-line chemotherapy of metastatic breast cancerLaure Favier, Nicolas Isambert, Sylvie Zanetta, et al.
Current Medical Research and Opinion|June 17, 2024
Overall survival of patients with CLL treated with ibrutinib in the first line compared to second-line ibrutinib after chemotherapy/chemoimmunotherapyTadeusz Robak, Michael Doubek, Emmanuelle Ferrant, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
European Journal of Cancer (Oxford, England : 1990)|June 26, 2020
Overall survival benefit of symptom monitoring in real-world patients with chronic lymphocytic leukaemia treated with ibrutinib: a FiLO group studyLoic Ysebaert, Anne Quinquenel, Fontané Bijou, et al.
Bulletin Du Cancer|January 29, 2019
Gilles Salles, Pierre Sesques, Emmanuelle Ferrant, et al.
Bulletin Du Cancer|November 6, 2007
[Angiogenesis targeting in breast cancer]Pierre Fumoleau, Bruno Coudert, Françoise Mayer, et al.
International Journal of Clinical Pharmacy|September 27, 2015
De-escalation chemotherapy and hematological profiles in patients with advanced Hodgkin's lymphomaAntoine Seignez, Olivier Casasnovas, Emmanuelle Ferrant, et al.
Cancer Cell|January 30, 2022
Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor T cell immunotherapy recipientsPierre Sesques, Emmanuel Bachy, Emmanuelle Ferrant, et al.
Gastroenterologie Clinique Et Biologique|January 27, 2005
[Sustained clinical response of large hepatocellular carcinoma after chemoembolization with pirarubicin, amiodarone and Lipiodol]Jean-Pierre Cercueil, Emmanuelle Ferrant, Nicolas Isambert, et al.
Clinical Case Reports|December 22, 2021
Crystal-storing histiocytosis and Bing-Neel-like syndrome revealing a small B-cell lymphoma with plasmacytic differentiation, presumed to be a marginal zone lymphomaHippolyte Lequain, Mathieu Gerfaud-Valentin, Juliette Fontaine, et al.
Leukemia|January 31, 2020
Impact of using leader primers for IGHV mutational status assessment in chronic lymphocytic leukemiaSarah Huet, Anne Bouvard, Emmanuelle Ferrant, et al.
Breast (Edinburgh, Scotland)|August 19, 2007
Results of a phase I trial of intravenous vinorelbine plus oral capecitabine as first-line chemotherapy of metastatic breast cancerLaure Favier, Nicolas Isambert, Sylvie Zanetta, et al.
Current Medical Research and Opinion|June 17, 2024
Overall survival of patients with CLL treated with ibrutinib in the first line compared to second-line ibrutinib after chemotherapy/chemoimmunotherapyTadeusz Robak, Michael Doubek, Emmanuelle Ferrant, et al.
Pageof 5